Your browser doesn't support javascript.
loading
Prevalence of COVID-19 in prison population: a meta-analysis of 35 studies.
SeyedAlinaghi, SeyedAhmad; Yarmohammadi, Soudabeh; Farahani Rad, Farid; Rasheed, Muhammad Ali; Javaherian, Mohammad; Afsahi, Amir Masoud; Siami, Haleh; Bagheri, AmirBehzad; Zand, Ali; Dadras, Omid; Mehraeen, Esmaeil.
Afiliação
  • SeyedAlinaghi S; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Yarmohammadi S; Kashan University of Medical Sciences, Kashan, Iran.
  • Farahani Rad F; Tehran University of Medical Sciences, Tehran, Iran.
  • Rasheed MA; Tehran University of Medical Sciences, Tehran, Iran.
  • Javaherian M; Tehran University of Medical Sciences, Tehran, Iran.
  • Afsahi AM; Department of Radiology, University of California, San Diego, CA, USA.
  • Siami H; Islamic Azad University, Shahreza, Iran.
  • Bagheri A; Baylor College of Medicine, Houston, Texas, USA.
  • Zand A; Tehran University of Medical Sciences, Tehran, Iran.
  • Dadras O; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Mehraeen E; Ardabil University of Medical Sciences, Ardabil, Iran and Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.
Article em En | MEDLINE | ID: mdl-39267228
ABSTRACT

PURPOSE:

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Considering the restricted and enclosed nature of prisons and closed environments and the prolonged and close contact between individuals, COVID-19 is more likely to have a higher incidence in these settings. This study aims to assess the prevalence of COVID-19 among prisoners. DESIGN/METHODOLOGY/

APPROACH:

Papers published in English from 2019 to July 7, 2023, were identified using relevant keywords such as prevalence, COVID-19 and prisoner in the following databases PubMed/MEDLINE, Scopus and Google Scholar. For the meta-analysis of the prevalence, Cochrane's Q statistics were calculated. A random effect model was used due to the heterogeneity in COVID-19 prevalence across included studies in the meta-analysis. All analyses were performed in STATA-13.

FINDINGS:

The pooled data presented a COVID-19 prevalence of 20% [95%CI 0.13, 0.26] and 24% [95%CI 0.07, 0.41], respectively, in studies that used PCR and antibody tests. Furthermore, two study designs, cross-sectional and cohort, were used. The results of the meta-analysis showed studies with cross-sectional and cohort designs reported 20% [95%CI 0.11, 0.29] and 25% [95%CI 0.13, 0.38], respectively. ORIGINALITY/VALUE Through more meticulous planning, it is feasible to reduce the number of individuals in prison cells, thereby preventing the further spread of COVID-19.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prisões / Prisioneiros / COVID-19 Limite: Humans Idioma: En Revista: Int J Prison Health (2024) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prisões / Prisioneiros / COVID-19 Limite: Humans Idioma: En Revista: Int J Prison Health (2024) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido